Biotech · Public company · Alameda, CA, US

Exelixis, Inc.

Ticker EXEL · SEC CIK 0000939767

Track this companyFree. Adds Exelixis, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2525 recruiting or active

Pipeline programs25From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline25

AbirateronePhase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
AtezolizumabPhase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
CabozantinibPhase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
CabozantinibPhase 3 · Differentiated Thyroid CancerClinicalTrials.gov · fetched Nov 12, 2026
CabozantinibPhase 3 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
EverolimusPhase 3 · Pancreatic Neuroendocrine Tumor (pNET)ClinicalTrials.gov · fetched Nov 12, 2026
IpilimumabPhase 3 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 3 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
PrednisonePhase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
ZanzalintinibPhase 3 · Pancreatic Neuroendocrine Tumor (pNET)ClinicalTrials.gov · fetched Nov 12, 2026
ZanzalintinibPhase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
ZanzalintinibPhase 2 · MeningiomaClinicalTrials.gov · fetched Nov 12, 2026
atezolizumabPhase 1 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
cabozantinibPhase 1 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
DocetaxelPhase 1 · Renal Cell Carcinoma (RCC)ClinicalTrials.gov · fetched Nov 12, 2026
IpilimumabPhase 1 · Renal Cell Carcinoma (RCC)ClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 1 · Renal Cell Carcinoma (RCC)ClinicalTrials.gov · fetched Nov 12, 2026
Nivolumab + RelatlimabPhase 1 · Renal Cell Carcinoma (RCC)ClinicalTrials.gov · fetched Nov 12, 2026
OlaparibPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 1 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PrednisonePhase 1 · Renal Cell Carcinoma (RCC)ClinicalTrials.gov · fetched Nov 12, 2026
XB010Phase 1 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
XL309Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
ZanzalintinibPhase 1 · Renal Cell Carcinoma (RCC)ClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular CarcinomaPHASE1_PHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07878689 · fetched Nov 12, 2026
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored StudyPHASE3 · ENROLLING_BY_INVITATION · started Jul 30, 2026ClinicalTrials.gov NCT07620574 · fetched Nov 12, 2026
A Study of Zanzalintinib in Participants With Recurrent or Progressive MeningiomaPHASE2 · RECRUITING · started May 21, 2026ClinicalTrials.gov NCT07428616 · fetched Nov 12, 2026
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue SarcomaPHASE2 · RECRUITING · started Apr 14, 2026ClinicalTrials.gov NCT07283731 · fetched Nov 12, 2026
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)PHASE3 · RECRUITING · started Apr 9, 2026ClinicalTrials.gov NCT07489495 · fetched Nov 12, 2026
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)PHASE2 · RECRUITING · started Dec 9, 2025ClinicalTrials.gov NCT06926634 · fetched Nov 12, 2026
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)PHASE2 · RECRUITING · started Dec 5, 2025ClinicalTrials.gov NCT07193550 · fetched Nov 12, 2026
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine CancerPHASE1 · RECRUITING · started Oct 17, 2025ClinicalTrials.gov NCT06795009 · fetched Nov 12, 2026
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before SurgeryPHASE2 · RECRUITING · started Jul 22, 2025ClinicalTrials.gov NCT06959511 · fetched Nov 12, 2026
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsPHASE2_PHASE3 · RECRUITING · started Jul 21, 2025ClinicalTrials.gov NCT06943755 · fetched Nov 12, 2026
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)PHASE1_PHASE2 · RECRUITING · started Jul 20, 2025ClinicalTrials.gov NCT07049926 · fetched Nov 12, 2026
XL092 and Cemiplimab in BRAF WT Thyroid CancerPHASE1 · RECRUITING · started Jun 3, 2025ClinicalTrials.gov NCT06902376 · fetched Nov 12, 2026
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)PHASE1_PHASE2 · RECRUITING · started Feb 14, 2025ClinicalTrials.gov NCT06835972 · fetched Nov 12, 2026
Study of XB010 in Subjects With Solid TumorsPHASE1 · RECRUITING · started Aug 6, 2024ClinicalTrials.gov NCT06545331 · fetched Nov 12, 2026
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 3, 2024ClinicalTrials.gov NCT05932862 · fetched Nov 12, 2026
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)PHASE2 · RECRUITING · started Dec 20, 2023ClinicalTrials.gov NCT05931393 · fetched Nov 12, 2026
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 2, 2023ClinicalTrials.gov NCT05502315 · fetched Nov 12, 2026
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsPHASE1 · RECRUITING · started Dec 14, 2021ClinicalTrials.gov NCT05176483 · fetched Nov 12, 2026
Cabozantinib in High Grade Neuroendocrine NeoplasmsPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 24, 2020ClinicalTrials.gov NCT04412629 · fetched Nov 12, 2026
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular CarcinomaPHASE2 · RECRUITING · started Aug 7, 2020ClinicalTrials.gov NCT04472767 · fetched Nov 12, 2026
Pan Tumor Rollover StudyPHASE2 · RECRUITING · started Aug 9, 2019ClinicalTrials.gov NCT03899155 · fetched Nov 12, 2026
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell CarcinomaPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 25, 2019ClinicalTrials.gov NCT03937219 · fetched Nov 12, 2026
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted TherapyPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 5, 2018ClinicalTrials.gov NCT03690388 · fetched Nov 12, 2026
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 5, 2017ClinicalTrials.gov NCT03170960 · fetched Nov 12, 2026
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityPHASE2 · RECRUITING · started Jul 1, 2012ClinicalTrials.gov NCT01639508 · fetched Nov 12, 2026

SEC filings12

10-Q · 10-QSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Sep 11, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 31, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 29, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
10-K · 10-KSEC EDGAR · filed Feb 10, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Feb 10, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jan 12, 2026 · fetched Nov 12, 2026